Funded Tech Companies

Taligen Therapeutics

Taligen Therapeutics was a biopharmaceutical company, based in Aurora. Taligen Therapeutics was acquired by Alexion Pharmaceuticals.

Company Overview

Company Name
Taligen Therapeutics
Company Status
Acquired or Merged

Contact Information

Mailing Address
12635 East Montview Blvd 223
Aurora, CO 80045
USA
Email Address

Company Background Information

Overview
Taligen's lead technology is directed at inhibiting factor B, an essential component in the amplification of complement activation. Inhibition of factor B down-regulates complement activation, thereby dampening the inflammatory response.
Profile
Taligen Therapeutics LinkedIn Company Profile
Social Media
Taligen Therapeutics Company Twitter Account
Company News
Taligen Therapeutics News
Facebook
Taligen Therapeutics on Facebook
YouTube
Taligen Therapeutics on YouTube
Last Transaction
1/31/2011

Financing History

Date
Type
Amount
M&A
$111,000,000
Venture Equity
$10,000,000
Venture Equity
$26,000,000
Venture Equity
$5,000,000
Venture Equity
$65,000,000
Venture Equity
$2,800,000


Management Team

Title
Name
Email & Social
Chief Executive Officer
Abbie Celniker
  Abbie Celniker LinkedIn Profile  Abbie Celniker Twitter Account  Abbie Celniker News  Abbie Celniker on Facebook
Chief Scientific Officer
Michael Holers
  Michael Holers LinkedIn Profile  Michael Holers Twitter Account  Michael Holers News  Michael Holers on Facebook
President
Woodruff Emlen
  Woodruff Emlen LinkedIn Profile  Woodruff Emlen Twitter Account  Woodruff Emlen News  Woodruff Emlen on Facebook


Company Investors

 

 

 

Browse more funded tech companies:

Talespin | Talima Therapeutics

 

Share this article

 


About Our VC & M&A Database

This tech company profile is powered by VentureDeal.com, a market leader in private equity transaction data.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary